Brain

Infants learn to look and look to learn

Researchers at the University of Iowa have documented an activity by infants that begins nearly from birth: They learn by taking inventory of the things they see.

In a new paper, the psychologists contend that infants create knowledge by looking at and learning about their surroundings. The activities should be viewed as intertwined, rather than considered separately, to fully appreciate how infants gain knowledge and how that knowledge is seared into memory.

Could high insulin make you fat? Mouse study says yes

When we eat too much, obesity may develop as a result of chronically high insulin levels, not the other way around. That's according to new evidence in mice reported in the December 4th Cell Metabolism, a Cell Press publication, which challenges the widespread view that rising insulin is a secondary consequence of obesity and insulin resistance.

Study: Parents key to preventing alcohol, marijuana use by kids

New research from North Carolina State University, Brigham Young University and the Pennsylvania State University finds that parental involvement is more important than the school environment when it comes to preventing or limiting alcohol and marijuana use by children.

Multiple media use tied to depression, anxiety

EAST LANSING, Mich. — Using multiple forms of media at the same time – such as playing a computer game while watching TV – is linked to symptoms of anxiety and depression, scientists have found for the first time.

Michigan State University's Mark Becker, lead investigator on the study, said he was surprised to find such a clear association between media multitasking and mental health problems. What's not yet clear is the cause.

Research shows immune system response is detrimental to novel brain cancer therapy

Boston -- For the first time, researchers have demonstrated that the response of natural killer (NK) cells is detrimental to glioblastoma virotherapy, a novel way of treating malignant brain cancer by injecting a virus into the tumor. A number of clinical trials are currently underway to test whether glioblastoma virotherapy will facilitate antitumor efficacy, but research led by E.

The radical restructuring of brain networks in comatose patients

The researchers are focusing on analysing brain networks of brain-damaged comatose (non-traumatised) patients, a state where the individual is considered to be unconscious.

Understanding anger, overcoming anxiety

Montreal, December 4, 2012 – Anger is a powerful emotion with serious health consequences. A new study from Concordia University shows that for millions of individuals around the world who suffer from Generalized Anxiety Disorder (GAD), anger is more than an emotion; it's an agent that exacerbates their illness.

Web-based project prevents epilepsy-related depression

Emory researchers announced results of a new study that has proven successful in the prevention of depression in people diagnosed with epilepsy.

Depression is one of the most common psychiatric disorders in people with epilepsy. It affects between 32 and 48 percent of people with the disease. Depression is known to have more of an impact on quality of life than frequent seizures.

Barrow researchers successfully destroy brain tumor cells

Phoenix, AZ Dec. 2, 2012) -- A team of brain cancer researchers at Barrow Neurological Institute at St. Joseph's Hospital and Medical Center has effectively treated brain tumor cells using a unique combination of diet and radiation therapy. The study, "The Ketogenic Diet Is an Effective Adjuvant to Radiation Therapy for the Treatment of Malignant Glioma," was published in PLOS ONE.

Diabetes drug may reduce brain damage after stroke

In a study in mice, scientists at Karolinska Institutet in Sweden have discovered a new potential therapy that may reduce brain damage following stroke in type 2 diabetic patients. The suggested drug is already approved for the treatment of type 2 diabetes. However, the scientists hope that this new results, presented in the scientific journal Diabetes, also opens up the possibility to decrease brain injury after stroke in other patient groups with a high stroke risk.

Emigration of children to urban areas can protect parents against depression

Parents whose children move far away from home are less likely to become depressed than parents with children living nearby, according to a new study of rural districts in Thailand. The study, led by scientists at King's College London, suggests that children who migrate to urban areas are more likely to financially support their parents, which may be a factor for lower levels of depression.

Why older adults become fraud victims more often

Why are older people especially vulnerable to becoming victims of fraud? A new UCLA study indicates that an important clue may lie in a particular region of the brain that influences the ability to discern who is honest and who is trying to deceive us.

Research from King's College London reveals why some teenagers more prone to binge drinking

New research helps explain why some teenagers are more prone to drinking alcohol than others. The study, led by King's College London's Institute of Psychiatry (IoP) and published in Proceedings of National Academy of Sciences (PNAS) provides the most detailed understanding yet of the brain processes involved in teenage alcohol abuse.

Women with sleep apnea have higher degree of brain damage than men, UCLA study shows

Women suffering from sleep apnea have, on the whole, a higher degree of brain damage than men with the disorder, according to a first-of-its-kind study conducted by researchers at the UCLA School of Nursing. The findings are reported in the December issue of the peer-reviewed journal SLEEP.

University of Minnesota researchers find new target for Alzheimer's drug development

MINNEAPOLIS/ST. PAUL (December 3, 2012) – Researchers at the University of Minnesota's Center for Drug Design have developed a synthetic compound that, in a mouse model, successfully prevents the neurodegeneration associated with Alzheimer's disease.

In the pre-clinical study, researchers Robert Vince, Ph.D.; Swati More, Ph.D.; and Ashish Vartak, Ph.D., of the University's Center for Drug Design, found evidence that a lab-made compound known as psi-GSH enables the brain to use its own protective enzyme system, called glyoxalase, against the Alzheimer's disease process.